Abstract |
Insulin-like growth factor binding proteins (IGFBPs) are modulators of numerous cellular processes including cell proliferation. Although IGFBPs classically act by sequestration of extracellular insulin-like growth factors (IGFs), thereby contributing to the fine-tuning of growth factor signals, IGF-independent actions of IGFBPs have also been described. In the breast, growth factor signaling in association with estradiol (E2)-stimulated estrogen receptor function is organized in a complex cross-talk. The importance of phosphatidylinositol 3-kinase/ protein kinase B (Akt/PKB) pathway components for the E2-induced activation of estrogen receptor-alpha (ERα) is well accepted. Here we show that in the absence of IGFs, IGFBP-4 or IGFBP-5, either overexpressed in MCF-7 breast cancer cells or added exogenously, decreased the capability of E2 to induce ERα transcriptional activity. In addition, overexpression or addition of recombinant IGFBP-4 or IGFBP-5 resulted in reduction of E2-induced phosphorylation of Akt/PKB, GSK-3α/β and ERα in MCF-7 cells. The activation of the Akt/PKB-pathway describes a non-genomic effect of E2, which did not involve activation/phosphorylation of the IGF-I receptor (IGF-IR). Furthermore, knockdown of the IGF-IR did not affect the inhibition of E2-induced ERα phosphorylation by IGFBP-4 and 5. Moreover, IGFBP-4 and IGFBP-5 strongly decreased E2-triggered growth of MCF-7 cells. Our data suggest that IGFBPs interfere with the E2-induced activation of the Akt/PKB-pathway and prevent full hormone-dependent activation of ERα and breast cancer cell growth in an IGF- and IGF-IR-independent manner.
|
Authors | Alexander Hermani, Ashish Shukla, Senad Medunjanin, Haim Werner, Doris Mayer |
Journal | Cellular signalling
(Cell Signal)
Vol. 25
Issue 6
Pg. 1395-402
(Jun 2013)
ISSN: 1873-3913 [Electronic] England |
PMID | 23499909
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- Estrogen Receptor alpha
- Insulin-Like Growth Factor Binding Protein 4
- Insulin-Like Growth Factor Binding Protein 5
- RNA, Messenger
- RNA, Small Interfering
- Recombinant Proteins
- Estradiol
- Insulin-Like Growth Factor I
- Receptor, IGF Type 1
- Proto-Oncogene Proteins c-akt
- Glycogen Synthase Kinase 3
- glycogen synthase kinase 3 alpha
|
Topics |
- Breast Neoplasms
(metabolism, pathology)
- Cell Proliferation
(drug effects)
- Estradiol
(pharmacology)
- Estrogen Receptor alpha
(genetics, metabolism)
- Female
- Glycogen Synthase Kinase 3
(metabolism)
- Humans
- Insulin-Like Growth Factor Binding Protein 4
(genetics, metabolism)
- Insulin-Like Growth Factor Binding Protein 5
(genetics, metabolism)
- Insulin-Like Growth Factor I
(metabolism)
- MCF-7 Cells
- Phosphorylation
(drug effects)
- Proto-Oncogene Proteins c-akt
(metabolism)
- RNA Interference
- RNA, Messenger
(metabolism)
- RNA, Small Interfering
(metabolism)
- Receptor, IGF Type 1
(antagonists & inhibitors, genetics, metabolism)
- Recombinant Proteins
(biosynthesis, genetics, pharmacology)
- Signal Transduction
(drug effects)
- Transcription, Genetic
|